I saw this posted on the "ME/CFS-Evolving Science" facebook page...
Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome
Eiren Sweetman, Margaret Ryan, Christina Edgar, Angus MacKay, Rosamund Vallings, Warren...
Open access (PDF file) at https://www.nature.com/articles/s41586-018-0846-z.epdf?shared_access_token=WAkCBVS3L3DO0bM6CbjKJ9RgN0jAjWel9jnR3ZoTv0NUSr5JeVHn5ILb4ngHL_BsTJMx2GJRjntjSBzshFZ8yE4tC3l6CzSLy6_zVux-gc6CNyCRZyfQaZAXy__EeJqkVjgWHo5q5hftEAvdjdhYIjKN3PqYRuicN1bmJ64vvgs%3D
An old study but, as shown in this thread, https://s4me.info/threads/top-10-sc...f-citations-tweet-by-dr-mark-gutheridge.7461/, one of the most cited ME/CFS papers in the past 10 years, so thought it might be useful to have here.
Open access at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680051/
Not specifically about ME, but includes CFS in the list of conditions considered.
https://www.sciencedirect.com/science/article/pii/S1567724918301053#tf0005
Didn't find it elsewhere:
I've just realized the publication and article are from 2012:
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128%2812%2900104-7
(Kramer, Engquist).
Maybe still interesting for "ME newbies" (like myself)?
And what did become of it?
Very interesting use of mitochondria - as transplants to replace damaged versions in human organs.
https://mobile.nytimes.com/2018/07/10/health/mitochondria-transplant-heart-attack.html
https://www.ncbi.nlm.nih.gov/pubmed/29981562
The DOI (digital object identifier, aka ID number) for this doesn't seem to work, so I'm not sure anything beyond the abstract has been published yet.
Paywalled at https://www.cell.com/cell-metabolism/abstract/S1550-4131(18)30390-5
Article on the study
https://news.usc.edu/145046/mitochondrial-dna-nuclear-dna-work-together-usc-study/
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.